Related Experiment Video
Updated: Jan 24, 2026

10:06
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
Published on: February 26, 2018
7.8K
Tuberculosis and Short Bowel: A Therapeutic Challenge
Saurabh Mittal1, Karan Madan1, Nitish Aggarwal2
1Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.
Summary
Tuberculosis can cause short bowel syndrome, presenting a significant therapeutic challenge. Effective management requires a multidisciplinary approach to address both the infection and malabsorption.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Gastroenterology
Background:
- Tuberculosis (TB) is a global health concern.
- Short Bowel Syndrome (SBS) is a debilitating condition characterized by malabsorption.
- The co-occurrence of TB and SBS presents unique clinical and therapeutic complexities.
Purpose of the Study:
- To review the challenges in diagnosing and managing patients with concurrent tuberculosis and short bowel syndrome.
- To highlight the diagnostic difficulties and treatment strategies for this combined condition.
- To emphasize the need for a multidisciplinary approach in managing these complex cases.
Main Methods:
- Literature review of relevant studies and case reports.
- Analysis of clinical presentation, diagnostic modalities, and treatment outcomes.
- Discussion of therapeutic challenges and potential solutions.
Main Results:
- Tuberculosis can lead to or exacerbate short bowel syndrome through various mechanisms, including intestinal damage and obstruction.
- Diagnosis can be delayed due to overlapping symptoms with other gastrointestinal disorders.
- Management requires addressing active tuberculosis infection while simultaneously managing malabsorption and nutritional deficiencies.
Conclusions:
- The combination of tuberculosis and short bowel syndrome poses a significant therapeutic challenge.
- Early diagnosis and prompt, integrated management are crucial for improving patient outcomes.
- Further research is needed to optimize treatment protocols for this specific patient population.
Related Concept Videos
Pulmonary Tuberculosis I
883
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
883
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis V
559
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
559
Irritable Bowel Syndrome I: Introduction
947
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
947
Chronic Bowel Disorders: Introduction
764
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
764
Therapeutic Index
6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K

